All Categories

GMP Anti-MMRCD206 VHH

This time, Yaohai is really willing to post a new medicine publication suitable for curing chronic illnesses! For many years, researchers have been looking for ways to improve the treatment of these diseases. Crucial are these long-term diseases that can change the way people go through life as it could be difficult for them doing even their daily triggers like pushing up from a chair, walking or bending. So we are excited to share our newest creation, ‘GMP GLP-1GIP Tirzepatide API’. This new cure could be a game changer for those who have these types of evil diseases. 

Revolutionizing treatment options for autoimmune disorders

The new Research Article by Zheng et al., on page 10, describes a method for targeting CD206pos MMR expression with a novel GMP Anti-MMRCD206 VHH that could potentially revolutionize the management of autoimmunity. Our Immune system (our body defence system) tends to consider that our own healthy cells are harmful and starts attacking them. — So here develops Autoimmune diseases. This causes the immune system to attack its own tissues and throw the body into chaos. Conventional treatments for autoimmune diseases, such as medications and steroids, can cause serious side-effects. Unfortunately, they are not effective for everyone and that can be extremely frustrating to patients. To address this problem more accurately and to avoid the detrimental impact on other compartments of the immune system, we designed a novel form of treatment: GMP Anti-MMRCD206 VHH. This allows patients to get the help they need with fewer detrimental effects. 

Why choose Yaohai GMP Anti-MMRCD206 VHH?

Related product categories

Not finding what you're looking for?
Contact our consultants for more available products.

Request A Quote Now